130 related articles for article (PubMed ID: 23294798)
21. Can anyone stop the illegal sale of medicines online?
Jack A
BMJ; 2016 Mar; 352():i1317. PubMed ID: 26951841
[No Abstract] [Full Text] [Related]
22. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
23. Promotion of prescription drugs to consumers.
Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
[TBL] [Abstract][Full Text] [Related]
24. Prescription medication abuse and illegitimate internet-based pharmacies.
Jena AB; Goldman DP; Foster SE; Califano JA
Ann Intern Med; 2011 Dec; 155(12):848-50. PubMed ID: 22184692
[TBL] [Abstract][Full Text] [Related]
25. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Rollins BL
Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875
[TBL] [Abstract][Full Text] [Related]
26. Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel.
Tsai WH; Lancaster AR
Health Mark Q; 2012; 29(3):239-55. PubMed ID: 22905945
[TBL] [Abstract][Full Text] [Related]
27. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
Huh J; DeLorme DE; Reid LN; An S
Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the evidence: direct-to-consumer screening tests advertised online.
Lovett KM; Mackey TK; Liang BA
J Med Screen; 2012 Sep; 19(3):141-53. PubMed ID: 23093732
[TBL] [Abstract][Full Text] [Related]
29. What nurse practitioners should know about direct-to-consumer advertising of prescription medications.
Viale PH
J Am Acad Nurse Pract; 2003 Jul; 15(7):297-304. PubMed ID: 12929250
[TBL] [Abstract][Full Text] [Related]
30. The unintended consequences of argument dilution in direct-to-consumer drug advertisements.
Sivanathan N; Kakkar H
Nat Hum Behav; 2017 Nov; 1(11):797-802. PubMed ID: 31024121
[TBL] [Abstract][Full Text] [Related]
31. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
[TBL] [Abstract][Full Text] [Related]
32. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
33. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Carpentier FR
Int J Health Policy Manag; 2016 Feb; 5(4):283-5. PubMed ID: 27239874
[TBL] [Abstract][Full Text] [Related]
34. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs.
Kim SH; Ryu YJ; Cho NE; Kim AE; Chang J
Clin Drug Investig; 2017 Oct; 37(10):957-963. PubMed ID: 28735450
[TBL] [Abstract][Full Text] [Related]
35. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
Khalil Zadeh N; Robertson K; Green JA
BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
[TBL] [Abstract][Full Text] [Related]
36. Direct-to-consumer advertising.
Pines WL
Ann Pharmacother; 2000 Nov; 34(11):1341-4. PubMed ID: 11098351
[TBL] [Abstract][Full Text] [Related]
37. Direct-to-Consumer Advertising of Prescription Drugs Can Inform the Public and Improve Health.
Adams C
JAMA Oncol; 2016 Nov; 2(11):1395-1396. PubMed ID: 27532690
[No Abstract] [Full Text] [Related]
38. The US Opioid Crisis: Current Federal and State Legal Issues.
Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
[TBL] [Abstract][Full Text] [Related]
39. In the Biosimilar Marketplace Will There Be 50 Ways to Leave Your Insulin?
Carter AW
J Diabetes Sci Technol; 2016 Sep; 10(5):1188-91. PubMed ID: 26817993
[TBL] [Abstract][Full Text] [Related]
40. Regulation of prescription drug promotion: direct-to-consumer advertising.
Baylor-Henry M; Drezin NA
Clin Ther; 1998; 20 Suppl C():C86-95. PubMed ID: 9915094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
